Materials and Methods
Twenty-one adult female Sprague-Dawley rats weighing between 200 and 250 g were deeply anesthetized with intramuscular injections of 0.7 to 1.0 ml of a solution containing 1.4 mg/ml droperidol and 0.04 mg/ml fentanyl in saline. The rats were placed in a stereotactic frame, and a craniotomy was made over the right parietal cortex, with its center 3 mm posterior to the bregma and 2 mm lateral to the midline. A standardized small parietal contusion was produced by dropping a 24-g weight from a height of 4 cm onto a piston 1.0 mm in diameter, which rested on the dura. 13, 41 Four additional animals did not undergo operation and were used as controls.
Immunocytochemical Studies
Twelve of the rats undergoing operation as described above were reanesthetized and perfused with saline at body temperature followed by cold 4% (weight/volume (w/v)) paraformaldehyde in 0.15 M phosphate buffer (pH 7.3-7.4) at 2, 4, 7, and 14 days postlesioning, three at each postoperative survival time. The brains were postfixed in the same fixative for 1 to 2 hours and washed overnight at 4˚C in 0.15 M phosphate buffer with 10% (w/v) sucrose. Slices of the brains containing the entire lesion area were cut serially in 14-m slices on a cryostat. Sections were briefly air dried followed by incubation in normal horse serum (1:70) for 1 hour at room temperature. The sections were incubated overnight at 4˚C with the antibodies listed in Table 1 .
After a rinse in buffer the sections were incubated according to the avidin-biotin complex technique using a routine protocol 48 ( Table 1) . Phosphate-buffered saline (PBS) (0.15 M, pH 7.4) with 0.3% Triton X-100 was used in all incubation and rinsing steps. The following controls were performed prior to incubation with sections: omission of primary antiserum, and preabsorption of anti-rat C9 with rat C9 (0.1 mg/ml); 24 and anti-C3 with C3 (2.5 ϫ 10 Ϫ6 g/ml) and antiglial fibrillary acidic protein (GFAP) with GFAP (1 g/ml).
Immunofluorescence was used for double labelings. Three combinations of primary antibodies were used (Table 1 ): 1) antimicrotubule-associated protein 5 (anti-MAP5), which is a known marker for neurons 47 and anticlusterin; 2) anti-GFAP (astroglia) and anticlusterin; and 3) OX42 (microglia) and anti-C3. The antibodies were mixed and sections were incubated overnight at 4˚C, followed by a rinse in PBS. Fluorescein isothiocyanate (FITC)-or rhodamine-tagged secondary antibodies (anti-mouse and anti-rabbit, 1:40) were mixed and incubated with sections for 1 hour at room temperature. Sections were washed and mounted in glycerol with the antifading agent p-phenylenediamine. Sections were analyzed using a fluorescence microscope. The filter combinations were controlled with respect to their efficacy in clearly separating the emitted fluorescence. Thus, FITC-and rhodamine-labeled immune complexes could be unambiguously distinguished by the appropriate filter combinations for the two fluorophores.
In Situ Hybridization
Nine of the rats undergoing operation were killed at 2, 4, and 7 days postinjury, three at each postoperative survival time. Slices of the brains containing the lesion were frozen on dry ice. Fourteenmicrometer frontal sections were cut on a cryostat and mounted on sterilized slides coated with poly-L-lysine (50 l/ml). All sections were fixed in sterile 4% (w/v) paraformaldehyde in PBS (0.1 M, pH 7.4) at 4˚C for 30 minutes, followed by a wash in PBS. The sections were dehydrated in a graded ethanol series and air dried.
Oligonucleotide probes (48-mer, antisense) complementary to nucleotides 323 to 370 of clusterin, 8, 50 3301 to 3348 of complement C3, 10, 48 and 150 to 198 of GFAP 40, 49 were synthesized. A 48-mer sense probe previously described was used as a control. 50 The oligonucleotides were labeled at the 3Ј end with ␣[ 35 S]-dATP using terminal deoxyribonucleotidyl transferase to a specific activity of approximately 8 ϫ 10 8 cpm/g. The probes were purified using a nucleic acid purification cartridge. Hybridization was performed as described by Svensson, et al., 50 in 50% formamide, 4 ϫ SSC, 1 ϫ Denhardt's solution (0.02% polyvinylpyrrolidone, 0.02% Ficoll, 0.02% bovine serum albumin), 10% dextran sulfate, 0.25 mg/ml yeast transfer RNA, 0.05 mg/ml sheared salmon sperm DNA, 1% sarcosyl (N-lauroylsarcosine), 0.02 M NaPO 4 (pH 7.0), 50 mM dithiothreitol, and 5 ϫ 10 6 cpm/ml of probe. Sections were incubated with hybridization cocktail (100 l/ slide) overnight at 42˚C in a sealed chamber humidified with 50% (v/v) formamide, 0.6 M NaCl, 10 mM Tris HCl (pH 7.5), and 1 mM ethylenediamine tetraacetic acid. After hybridization the slides were removed from the chamber and washed in 1 ϫ SSC for 1 hour at 55˚C and for another hour at room temperature, followed by a brief rinse in water (2 minutes). The sections were dehydrated in a graded ethanol series and air dried prior to mounting for 1 to 3 weeks in an x-ray cassette together with ␤-max hyperfilm, after which these sections were dipped in Kodak NTB-2 photoemulsion diluted 1:1 in water. The sections were exposed for 1 to 4 weeks at 4˚C, developed in Kodak D19, counterstained with cresyl violet, dehydrated in a graded ethanol series to xylene and mounted in a nonaqueous medium using Eukitt. Five sections at 10 levels containing the contusion area from each animal (100 m between each level) were examined for each antibody or probe used.
Sources of Supplies and Equipment
Normal horse serum was supplied by Vector Laboratories, Burlingame, CA, and Triton X-100, p-phenylenediamine, and poly-Llysine by Sigma Chemical Co., St. Louis, MO. Glial fibrillary acidic protein and anti-GFAP were provided by Boehringer-Mannheim, GmbH Mannheim, Germany. Oligonucleotide probes were synthesized by Scandinavian Gene Synthesis AB, Köping, Sweden. Terminal deoxyribonucleotidyl transferase was supplied by IBI, New Haven, CT, and the Nen-sorb 20 nucleic acid purification cartridge was obtained from Du Pont Co., Wilmington, DE. The Eukitt was obtained from O. Klinger GmbH and Co., Freiburg, Germany.
The anti-mouse and anti-rat secondary antibodies were obtained from DAKO, Dakopatts, Denmark. The antibodies to clusterin/ SGP-2 were a generous gift from Drs. Michael Griswold and Steven R. Sylvester (Washington State University). The antibodies to complement factors were generously given by Dr. Paul Morgan (University of Wales College of Medicine).
Results

Immunocytochemical Studies
In the intact control brains, microglial as well as astroglial cells with fine processes labeled with OX42 and anti-GFAP, respectively, were present throughout the tissue (Fig. 2) . In the animals that underwent operation there was an increase in OX42-immunoreactivity (IR) (Fig. 2a  and b) , as well as GFAP-IR (Fig. 2d) around the lesion at all postoperative survival times. The OX42-as well as the GFAP-IR gradually increased during the first postoperative week.
Small vessels expressed tight junction-IR in the normal uninjured brains as well as contralateral to the injury (Fig.  3a and c) . However, tight junction-IR was absent around the lesion at all postoperative survival times examined ( Fig. 3a and b) . A general but rather diffuse increase in staining was present in the immediate vicinity of the contusion; however, this could be revealed as background staining following control incubations without the primary antibody. No ED1-IR was observed in intact brains or contralateral to the contusion injury (Fig. 3e) . However, numerous ED1-positive cells (Fig. 3d) with few processes were observed in the lesion area as well as in the zone roughly corresponding to the area lacking tight junction-IR (see above) at all postoperative survival times.
No C3d-or C9-IR was found in the brains of the control animals or in the contralateral hemisphere of the rats that underwent operation (Fig. 4d and f) . However, at 2, 4, 7, and 14 days postlesioning, immunoreactivity for both C3d (Fig. 4a and c) and C9 ( Fig. 4b and e) was found in the contusion region. The immunoreactivity seemed to peak at 4 days postlesioning. The C3d-IR appeared as fine granules on neuronal perikarya in the area surrounding the contusion (Fig. 4c) , whereas C9-IR was found in a similar pattern in neuronal perikarya in the vicinity of the contusion (Fig. 4e) . Some C3d-as well as C9-IR was found in a granular pattern in the neuropil close to the lesion ( Fig.  4c and e) .
No or low levels of clusterin-IR were found in the uninjured parietal cortex contralateral to the injury as well as in intact control animals (Fig. 5b) . However, there was a clear-cut increase of clusterin-IR in some of the neuronal perikarya in the vicinity to the contusion at 4, 7, and 14 days postlesion (Fig. 5a ). The immunoreactivity was most intense at 14 days. All control incubations including preabsorptions were negative.
Double Labelings
Neuronal perikarya in the contusion area labeled with antibodies to MAP5 showed a clear overlap with clusterin-IR ( Fig. 6a and b) . Clusterin-IR was also present in GFAP-positive astrocytes ( Fig. 6c and d) . There was an overlap as well between reactive microglia labeled with OX42 and C3-IR ( Fig. 6e and f) .
In Situ Hybridization
Grain density contralateral to the lesion in experimental as well as in control animals was equal to background levels using all probes (Figs. 7-9 ). At 2, 4, and 7 days postinjury there was an increase in grain density ipsilateral to the lesion following hybridization with the GFAP- (Fig. 7a) , C3- (Fig. 8a) , as well as clusterin-antisense (Fig. 9a) probes. The grains were concentrated over nonneuronal cells after incubation with the GFAP- (Fig. 7c) and C3-oligonucleotides (Fig. 8c ) most likely representing astroglia and microglia/macrophages, respectively (see double labelings above). A high density of grains was found over some of the neuronal perikarya in the lesion area after hybridization with the anticlusterin probe; however, some neurons in the same area expressed low levels of clusterin-messenger (m)RNA (Fig. 9c) . Radiolabeling was also found in the white matter beneath the contusion as well as in corpus callosum both ipsilateral and contralateral to the lesion after hybridization with GFAP- (Fig. 7a), C3-(Fig. 8a) , as well as clusterin-antisense (Fig.  9a) probes. There was no increase in grain density compared to background levels following incubations with the control probe in the animals that underwent operation (Figs. 7b, 8b, and 9b) .
Discussion
The present study has demonstrated an intense macrophage response and astroglial reaction followed by activation of the complement cascade in the ipsilateral hemisphere of the brain following a contusion injury. The damage to the BBB around the contusion was demonstrated by the absence of immunoreactivity for a tight junction protein normally present in small vessels, a finding that is in line with previous studies. 51, 52, 55 Invasion of inflammatory cells following injuries to the central nervous system has been reported in previous studies. 17, 19, 22, 26, 29 In the present study we found numerous cells in the contusion expressing ED1-IR, which is a known marker for monocytes/macrophages. The interactions of all these nonneuronal cells and their secreted products posttrauma are most likely important processes with impact on the clinical outcome following damage of the brain parenchyma. A wide variety of substances could be expected to be synthesized by these cells, for example, cytokines, eicosanoides, growth factors, and complement. The present study focuses on the possible presence of complement and its activation.
We found increased immunoreactivity for complement factors C3d and C9. Complement factor C3 is one of the key factors in the complement cascade, and the presence of C3d, which is a split fragment of C3, is an indication of activation of the cascade to the C3 level. The finding of C9-IR indicates that the entire cascade has been activated including the terminal pathway, which results in formation of the membrane attack complex consisting of C5b-9. The immunoreactivity for C3d as well as C9 was localized on neuronal perikarya in the vicinity of the lesion, suggesting that these neurons are targets for complement attack. Double labelings showed that reactive microglia expressed C3-IR, indicating that these cells are a local source of this complement component, which is in line with previous observations. 47 The time course of these changes indicates complement activation at all postoperative times examined. Two days was the earliest postoperative time included in the present study; however, the changes observed most likely begin at a somewhat earlier timepoint. Complement C3d-IR appeared as fine granules close to the neuronal cell membranes, which may represent sites of complement attack. Some C3d-as well as C9-IR was also found in the neuropil, perhaps on dendrites. However, to determine the exact ultrastructural localization of these factors electron microscopy analysis would be required, which is beyond the scope of the present study. Furthermore, we found an increase of C3-mRNA in nonneuronal cells ipsilateral to the lesion indicating a local synthesis of factor C3. Because C3-mRNA has been found in reactive microglia in the hypoglossal nucleus after peripheral nerve lesioning, 48 it is therefore likely that these cells are also the source of C3-mRNA following a brain contusion, although other macrophages may also be involved. In addition, double-labeling experiments in previous studies have shown that all complement factors detected so far are intimately associated with reactive microglia. 48, 50 Although only mRNA for C3, 48 C1qB, and C4 43 has been shown in microglia, these cells are a likely local source of most complement factors, like other cells of the macrophage family.
The membrane attack complex creates pores in the cell membranes through which an uncontrolled influx of, for example, calcium ions could occur, which may cause lysis and death of the target cell. Accumulation of membrane attack complex in sufficient amounts at the cell membranes of the neuronal perikarya may therefore be a significant factor in the spectrum of secondary injury mechanisms following trauma-induced neuronal death. In sublytic concentrations, however, the membrane attack complex may have a wide variety of other effects such as stimulation of proliferation and protein synthesis, as well as the release of cytokines, oxygen metabolites, and eicosanoids of target cells. 21, 37 All of these effects also seem to be related to an increased level of intracellular calcium. 36 Whether the presence of complement components in the brain after a contusion primarily reflects removal of tissue debris after the injury or if the major effects are part of an ongoing process of secondary injury mechanisms needs further examination.
Activation of complement in the brain contusion was followed by a somewhat later increase of clusterin, beginning at 4 days and increasing until 14 days postlesioning. Double labelings showed that clusterin was present in some of the neurons in the contusion region as well as in astroglial cells. In addition, clusterin-mRNA was increased in some of the neurons close to the lesion, whereas some neurons expressed low levels. Clusterin is considered to be involved in protecting homologous cells from complement attack by inhibiting the lytic action of the membrane attack complex. 31 We therefore suggest that the increase of clusterin in the injured neurons represents part of a program serving to protect them from complement attack. Clusterin has also been demonstrated in astrocytes in this study as well as in previous studies, 42, 50 suggesting that these glial cells have a neuroprotective role after trauma-induced complement activation. 18 In
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Complement activation following brain contusion addition, clusterin has been implicated in a number of other functions, for instance lipid transport, cell-cell interactions, and programmed cell death. 31, 36 In the present study we also observed an increase of GFAP-and C3-mRNA in the white matter beneath the contusion as well as along the corpus callosum to the contralateral side. This probably represents glial and complement activation in the vicinity of injured neurons that have axons traveling in the corpus callosum. Glial changes along an injured nerve tract have been described in previous studies, 30 and the changes described above probably represent a similar mechanism.
From our present results we suggest that activation of the complement cascade, including the terminal pathway, in the vicinity of a brain contusion may play a role in microglial/macrophage neurotoxicity, thereby representing an important process in the panorama of secondary injury mechanisms. Reactive macrophages have a central role in complement activation as a local source of C3 and probably other complement factors as well. The balance between complement attack and the upregulation of complement inhibitors in the injured neurons may have an impact on the degenerative events in the contusion and in particular the events leading to nerve cell death and therefore the functional restitution after traumatic brain injury.
